Atlas Trials

Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast Cancer

Clinical trial NCT01208480 · COMPLETED

Trial details

NCT number
NCT01208480
Sponsor
Severance Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer
Start date
2010-09-01
Primary completion
2012-02-01
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.